ArticleArchives of medical sciences. Atherosclerotic diseases2018

Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin?

Dimitrios Ioannis PatouliasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.